Pre-Open Stock Movers:

Locust Walk Acquisition Corp. (NASDAQ: LWAC) 162.5% HIGHER; announced today that the Company’s stockholders have approved all proposals related to the previously announced business combination with eFFECTOR Therapeutics, Inc. at a special meeting of stockholders held on August 24, 2021. Approximately 93.2% of the votes cast at the meeting on the Business Combination proposal, representing approximately 71.7% of LWAC’s outstanding shares, voted to approve the Business Combination.

Cassava Sciences (NASDAQ: SAVA) 30% LOWER; lawyer Jordon Thomas asked the FDA to halt drug trials.

Dick's Sporting Goods (NYSE: DKS) 14% HIGHER; reported Q2 EPS of $5.08, $2.38 better than the analyst estimate of $2.70. Revenue for the quarter came in at $3.27 billion versus the consensus estimate of $2.82 billion. Dick's Sporting Goods sees FY2021 EPS of $12.45-$12.95, versus the consensus of $9.01. Dick's Sporting Goods sees FY2021 revenue of $11.52-11.72 billion, versus the consensus of $10.9 billion.

Nordstrom (NYSE: JWN) 12.8% LOWER; reported Q2 EPS of $0.49, $0.21 better than the analyst estimate of $0.28. Revenue for the quarter came in at $3.66 billion versus the consensus estimate of $3.31 million. Revenue growth, including retail sales and credit card revenues of more than 35 percent.

BioLife Solutions Inc. (NASDAQ: BLFS) 10.8% HIGHER; will replace Saia in the S&P SmallCap 600

Limoneira (NASDAQ: LMNR) 10.7% LOWER; Prelim. Q3 Guidance Misses Consensus

Mimecast Limited (NASDAQ: MIME) 8.4% HIGHER; will replace Cinemark Holdings Inc. (NYSE: CNK) in the S&P MidCap 400

Option Care Health Inc. (NASDAQ: OPCH) 8% HIGHER; will replace Trustmark Corp. (NASDAQ: TRMK) in the S&P MidCap 400

Salarius Pharmaceuticals (NASDAQ: SLRX) 7.5% HIGHER; H.C. Wainwright analyst Michael King initiates coverage with a Buy rating and a price target of $5.00.

Urban Outfitters (NASDAQ: URBN) 5.2% LOWER; reported Q2 EPS of $1.28, $0.50 better than the analyst estimate of $0.78. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.08 billion.

Okta, Inc (NASDAQ: OKTA) 3.6% HIGHER; Raymond James upgraded from Outperform to Strong Buy with a price target of $310.00 (from $300.00)

Boston Beer Company (NYSE: SAM) 3% LOWER; Cowen downgraded from Market Perform to Underperform with a price target of $400.00 (from $825.00).

Beyond Meat Inc. (NASDAQ: BYND) 1.8% LOWER; Argus downgraded from Buy to Hold.

Intuit (NASDAQ: INTU) 1.6% HIGHER; reported Q4 EPS of $1.97, $0.29 better than the analyst estimate of $1.68. Revenue for the quarter came in at $2.6 billion versus the consensus estimate of $2.32 billion. Intuit sees FY2022 EPS of $11.05-$11.25, versus the consensus of $10.83. Intuit sees FY2022 revenue of $11.05-11.2 billion, versus the consensus of $10.94 billion. Intuit sees Q1 2022 EPS of $0.94-$0.99, versus the consensus of $1.14.

Bio-Techne Corp.(NASDAQ: TECH) 1% HIGHER; will replace Maxim Integrated Products Inc. (NASDAQ: MXIM) in the S&P 500